高级检索
当前位置: 首页 > 详情页

Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]China Japan Friendship Hosp, Tobacco Med & Tobacco Cessat Ctr, Beijing, Peoples R China [2]China Japan Friendship Hosp, Data & Project Management Unit, Beijing, Peoples R China [3]China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Beijing, Peoples R China [4]China Japan Friendship Hosp, Ctr Resp Med, Inst Clin Med Sci, Beijing, Peoples R China [5]China Japan Friendship Hosp, Data & Project Management Unit, Inst Clin Med Sci, Beijing, Peoples R China [6]WHO, Collaborating Ctr Tobacco Cessat & Resp Dis Preve, Beijing, Peoples R China [7]Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China [8]Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China [9]Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Inst Basic Med Sci, Beijing, Peoples R China [10]Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England [11]Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England [12]Capital Med Univ, Beijing Key Lab Resp & Pulm Circulat Disorders, Dept Pulm & Crit Care Med, Beijing, Peoples R China [13]Capital Med Univ, Dept Stomatol, Beijing, Peoples R China [14]Capital Med Univ, Dept Epidemiol, Beijing, Peoples R China [15]Capital Med Univ, Beijing Chao Yang Hosp, Dept Resp Med, Beijing, Peoples R China [16]Capital Med Univ, Clin Epidemiol & Evidence Based Med, Beijing, Peoples R China [17]Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Beijing, Peoples R China [18]Beijing Inst Resp Med, Beijing, Peoples R China [19]Shanxi Acad Med Sci, Dept Pulm & Crit Care Med, Shanxi Bethune Hosp, Taiyuan, Peoples R China [20]Xi An Jiao Tong Univ, Dept Pulm & Crit Care Med, Affiliated Hosp 1, Xian, Peoples R China [21]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Pulm & Crit Care Med,Wuhan,Peoples R China [22]Guizhou Prov Peoples Hosp, Dept Pulm & Crit Care Med, Guiyang, Peoples R China [23]Fudan Univ, Zhongshan Hosp, Dept Pulm & Crit Care Med, Shanghai, Peoples R China [24]China Med Univ, Dept Pulm & Crit Care Med, Hosp 1, Shenyang, Peoples R China [25]Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China [26]Zhejiang Univ, Dept Pulm & Crit Care Med, Sch Med, Affiliated Hosp 2, Hangzhou, Peoples R China [27]Sichuan Univ, State Key Lab Biotherapy China, West China Hosp, Chengdu, Peoples R China [28]Peking Univ, Dept Pulm & Crit Care Med, Hosp 3, Beijing, Peoples R China [29]Beijing Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China [30]Natl Ctr Gerontol, Beijing, Peoples R China [31]Imperial Coll London, Natl Heart & Lung Inst, London, England [32]Royal Brompton & Harefield NHS Trust, London, England [33]Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA
出处:
ISSN:

摘要:
Background Small airway dysfunction is a common but neglected respiratory abnormality. Little is known about its prevalence, risk factors, and prognostic factors in China or anywhere else in the world. We aimed to estimate the prevalence of small airway dysfunction using spirometry before and after bronchodilation, both overall and in specific population subgroups; assess its association with a range of lifestyle and environmental factors (particularly smoking); and estimate the burden of small airway dysfunction in China. Methods From June, 2012, to May, 2015, the nationally representative China Pulmonary Health study invited 57 779 adults to participate using a multistage stratified sampling method from ten provinces (or equivalent), and 50 479 patients with valid lung function testing results were included in the analysis. We diagnosed small airway dysfunction on the basis of at least two of the following three indicators of lung function being less than 65% of predicted: maximal mid-expiratory flow, forced expiratory flow (FEF) 50%, and FEF 75%. Small airway dysfunction was further categorised into pre-small airway dysfunction (defined as having normal FEV, and FEV,/forced vital capacity [FVC] ratio before bronchodilator inhalation), and post-small airway dysfunction (defined as having normal FEV1 and FEV1/FVC ratio both before and after bronchodilator inhalation). Logistic regression yielded adjusted odds ratios (ORs) for small airway dysfunction associated with smoking and other lifestyle and environmental factors. We further estimated the total number of cases of small airway dysfunction in China by applying present study findings to national census data. Findings Overall the prevalence of small airway dysfunction was 43.5% (95% CI 40.7-46.3), pre-small airway dysfunction was 25.5% (23.6-27.5), and post-small airway dysfunction was 11.3% (10.3-12.5). After multifactor regression analysis, the risk of small airway dysfunction was significantly associated with age, gender, urbanisation, education level, cigarette smoking, passive smoking, biomass use, exposure to high particulate matter with a diameter less than 2.5 mu m (PM2.5) concentrations, history of chronic cough during childhood, history of childhood pneumonia or bronchitis, parental history of respiratory diseases, and increase of body-mass index (BMI) by 5 kg/m(2). The ORs for small airway dysfunction and pre-small airway dysfunction were similar, whereas larger effect sizes were generally seen for post-small airway dysfunction than for either small airway dysfunction or presmall airway dysfunction. For post-small airway dysfunction, cigarette smoking, exposure to PM2.5, and increase of BMI by S kg/m(2) were significantly associated with increased risk, among preventable risk factors. There was also a dose-response association between cigarette smoking and post-small airway dysfunction among men, but not among women. We estimate that, in 2015, 426 (95% CI 411-468) million adults had small airway dysfunction, 253 (238-278) million had pre-small airway dysfunction, and 111 (104-126) million had post-small airway dysfunction in China. Interpretation In China, spirometry-defined small airway dysfunction is highly prevalent, with cigarette smoking being a major modifiable risk factor, along with PM2.5 exposure and increase of BMI by 5 kg/m(2). Our findings emphasise the urgent need to develop and implement effective primary and secondary prevention strategies to reduce the burden of this condition in the general population. Copyright (C) 2020 Elsevier Ltd. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 1 区 医学
小类 | 1 区 危重病医学 1 区 呼吸系统
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 危重病医学 1 区 呼吸系统
JCR分区:
出版当年[2018]版:
Q1 RESPIRATORY SYSTEM Q1 CRITICAL CARE MEDICINE
最新[2024]版:
Q1 CRITICAL CARE MEDICINE Q1 RESPIRATORY SYSTEM

影响因子: 最新[2024版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]China Japan Friendship Hosp, Tobacco Med & Tobacco Cessat Ctr, Beijing, Peoples R China [6]WHO, Collaborating Ctr Tobacco Cessat & Resp Dis Preve, Beijing, Peoples R China [7]Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China [8]Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China
通讯作者:
通讯机构: [3]China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Beijing, Peoples R China [6]WHO, Collaborating Ctr Tobacco Cessat & Resp Dis Preve, Beijing, Peoples R China [7]Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China [8]Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China [15]Capital Med Univ, Beijing Chao Yang Hosp, Dept Resp Med, Beijing, Peoples R China [*1]China Japan Friendship Hosp, Ctr Resp Med, Dept Pulm & Crit Care Med, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:622 今日访问量:0 总访问量:452 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)